Home › Obesity › Arizona › Phoenix

Pag-aaral pangklinika para sa Obesity sa Phoenix, AZ

19 pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Phoenix (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Nagre-recruitPhase 4

Medical Dermatology Specialists, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06857942

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3

RIO Clinical Trials - Phoenix, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3

Elite Clinical Studies, LLC, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07353931

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2

Helios Clinical Research - Phoenix, Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06897475

Early Tracking of Childhood Health Determinants (ETCHED) Study

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

NIDDK, Phoenix, Phoenix

1 Day – 99 Years · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03481829

Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)

Nagre-recruitPhase 1

Arizona Research Center, Phoenix

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07908316

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Nagre-recruitPhase 3

Medical Advancement Centers of Arizona, Phoenix

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07037459

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3

Research Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Nagre-recruitObservasyonal na pag-aaral

Exponent Phoenix, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07776678

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

ACCOMPLISH-2 Research Site, Phoenix

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07654374

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

NIDDK, Phoenix, Phoenix

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06223555

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3

AURORA-2 Clinical Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3

AURORA-1 Clinical Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

NIDDK, Phoenix, Phoenix

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05545306

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Nagre-recruitPhase 3

Honor Health, Phoenix
Arizona Research Center, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Phoenix

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Fibrosis Lessens After Metabolic Surgery

Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo

Banner Health Center, Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06374875

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Nagre-recruitPhase 3

Arizona Research Center, Inc., Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07481630

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Nagre-recruitPhase 3

The University of Arizona College of Medicine- Phoenix, Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT06499857

Pag-aaral para sa Obesity sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.